ID   ZDHC5_RAT               Reviewed;         715 AA.
AC   Q2THW7;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   02-OCT-2024, entry version 115.
DE   RecName: Full=Palmitoyltransferase ZDHHC5;
DE            EC=2.3.1.225 {ECO:0000250|UniProtKB:Q8VDZ4};
DE   AltName: Full=Zinc finger DHHC domain-containing protein 5;
DE            Short=DHHC-5;
GN   Name=Zdhhc5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Chen Y., Huang C.-H.;
RT   "A superfamily of membrane-associated DHHC type zinc finger proteins.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   INTERACTION WITH SSTR5.
RX   PubMed=21820437; DOI=10.1016/j.febslet.2011.07.028;
RA   Kokkola T., Kruse C., Roy-Pogodzik E.M., Pekkinen J., Bauch C., Honck H.H.,
RA   Hennemann H., Kreienkamp H.J.;
RT   "Somatostatin receptor 5 is palmitoylated by the interacting ZDHHC5
RT   palmitoyltransferase.";
RL   FEBS Lett. 585:2665-2670(2011).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-425; SER-554 AND
RP   SER-621, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   PALMITOYLATION, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=31547976; DOI=10.1016/j.bpj.2019.08.018;
RA   Chen J.J., Marsden A.N., Scott C.A., Akimzhanov A.M., Boehning D.;
RT   "DHHC5 Mediates beta-Adrenergic Signaling in Cardiomyocytes by Targeting
RT   Galpha Proteins.";
RL   Biophys. J. 118:826-835(2020).
CC   -!- FUNCTION: Palmitoyltransferase that catalyzes the addition of palmitate
CC       onto various protein substrates such as CTNND2, CD36, GSDMD, NLRP3,
CC       NOD1, NOD2, STAT3 and S1PR1 thus plays a role in various biological
CC       processes including cell adhesion, inflammation, fatty acid uptake,
CC       bacterial sensing or cardiac functions (PubMed:31547976). Plays an
CC       important role in the regulation of synapse efficacy by mediating
CC       palmitoylation of delta-catenin/CTNND2, thereby increasing synaptic
CC       delivery and surface stabilization of alpha-amino-3-hydroxy-5-methyl-4-
CC       isoxazole propionic acid receptors (AMPARs) (By similarity). Under
CC       basal conditions, remains at the synaptic membrane through FYN-mediated
CC       phosphorylation that prevents association with endocytic proteins (By
CC       similarity). Neuronal activity enhances the internalization and
CC       trafficking of DHHC5 from spines to dendritic shafts where it
CC       palmitoylates delta-catenin/CTNND2 (By similarity). Regulates cell
CC       adhesion at the plasma membrane by palmitoylating GOLGA7B and DSG2 (By
CC       similarity). Plays a role in innate immune response by mediating the
CC       palmitoylation of NOD1 and NOD2 and their proper recruitment to the
CC       bacterial entry site and phagosomes (By similarity). Participates also
CC       in fatty acid uptake by palmitoylating CD36 and thereby targeting it to
CC       the plasma membrane (By similarity). Upon binding of fatty acids to
CC       CD36, gets phosphorylated by LYN leading to inactivation and subsequent
CC       CD36 caveolar endocytosis (By similarity). Controls oligodendrocyte
CC       development by catalyzing STAT3 palmitoylation (By similarity). Acts as
CC       a regulator of inflammatory response by mediating palmitoylation of
CC       NLRP3 and GSDMD (By similarity). Palmitoylates NLRP3 to promote
CC       inflammasome assembly and activation (By similarity). Activates
CC       pyroptosis by catalyzing palmitoylation of gasdermin-D (GSDMD), thereby
CC       promoting membrane translocation and pore formation of GSDMD (By
CC       similarity). {ECO:0000250|UniProtKB:Q8VDZ4,
CC       ECO:0000250|UniProtKB:Q9C0B5, ECO:0000269|PubMed:31547976}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + L-cysteinyl-[protein] = CoA + S-
CC         hexadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:36683, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:11032, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:74151;
CC         EC=2.3.1.225; Evidence={ECO:0000250|UniProtKB:Q8VDZ4};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36684;
CC         Evidence={ECO:0000250|UniProtKB:Q8VDZ4};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:31547976};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: The DHHC domain is required for palmitoyltransferase activity.
CC       {ECO:0000250|UniProtKB:Q8IUH5}.
CC   -!- PTM: Autopalmitoylated (By similarity). Palmitoylation of the C-
CC       terminal tail regulates stimulation-dependent plasma membrane motility
CC       (PubMed:31547976). {ECO:0000250|UniProtKB:Q9C0B5,
CC       ECO:0000269|PubMed:31547976}.
CC   -!- PTM: Phosphorylation regulates association with endocytic proteins and
CC       its subcellular localization. Phosphorylation by LYN during fatty acid
CC       uptake leads to inactivation of the activity.
CC       {ECO:0000250|UniProtKB:Q9C0B5}.
CC   -!- SIMILARITY: Belongs to the DHHC palmitoyltransferase family.
CC       ERF2/ZDHHC9 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY871203; AAX68536.1; -; mRNA.
DR   RefSeq; NP_001034427.1; NM_001039338.1.
DR   RefSeq; XP_017447385.1; XM_017591896.1.
DR   RefSeq; XP_017447386.1; XM_017591897.1.
DR   RefSeq; XP_017447387.1; XM_017591898.1.
DR   AlphaFoldDB; Q2THW7; -.
DR   SMR; Q2THW7; -.
DR   STRING; 10116.ENSRNOP00000009708; -.
DR   iPTMnet; Q2THW7; -.
DR   PhosphoSitePlus; Q2THW7; -.
DR   SwissPalm; Q2THW7; -.
DR   PaxDb; 10116-ENSRNOP00000009708; -.
DR   Ensembl; ENSRNOT00000009708.6; ENSRNOP00000009708.4; ENSRNOG00000006832.7.
DR   Ensembl; ENSRNOT00055034987; ENSRNOP00055028389; ENSRNOG00055020498.
DR   Ensembl; ENSRNOT00060018240; ENSRNOP00060014200; ENSRNOG00060010772.
DR   Ensembl; ENSRNOT00065037224; ENSRNOP00065030031; ENSRNOG00065021876.
DR   GeneID; 362156; -.
DR   KEGG; rno:362156; -.
DR   UCSC; RGD:1589737; rat.
DR   AGR; RGD:1589737; -.
DR   CTD; 25921; -.
DR   RGD; 1589737; Zdhhc5.
DR   eggNOG; KOG1311; Eukaryota.
DR   GeneTree; ENSGT00940000156001; -.
DR   HOGENOM; CLU_013779_0_0_1; -.
DR   InParanoid; Q2THW7; -.
DR   OMA; LAPRYMG; -.
DR   OrthoDB; 5480099at2759; -.
DR   PhylomeDB; Q2THW7; -.
DR   TreeFam; TF354263; -.
DR   BRENDA; 2.3.1.225; 5301.
DR   PRO; PR:Q2THW7; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000006832; Expressed in esophagus and 18 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0099091; C:postsynaptic specialization, intracellular component; IDA:SynGO.
DR   GO; GO:0016409; F:palmitoyltransferase activity; ISO:RGD.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006869; P:lipid transport; IEA:UniProtKB-KW.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; ISO:RGD.
DR   GO; GO:0062208; P:positive regulation of pattern recognition receptor signaling pathway; ISO:RGD.
DR   GO; GO:1905171; P:positive regulation of protein localization to phagocytic vesicle; ISO:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0140639; P:positive regulation of pyroptotic inflammatory response; ISS:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IDA:SynGO.
DR   InterPro; IPR051108; DHHC_palmitoyltransf.
DR   InterPro; IPR001594; Palmitoyltrfase_DHHC.
DR   PANTHER; PTHR12349; ANKYRIN REPEAT AND LEM DOMAIN-CONTAINING PROTEIN 2; 1.
DR   PANTHER; PTHR12349:SF3; PALMITOYLTRANSFERASE ZDHHC5; 1.
DR   Pfam; PF01529; DHHC; 1.
DR   PROSITE; PS50216; DHHC; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Cell membrane; Immunity; Innate immunity; Lipid transport;
KW   Lipoprotein; Membrane; Methylation; Palmitate; Phosphoprotein;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..715
FT                   /note="Palmitoyltransferase ZDHHC5"
FT                   /id="PRO_0000418364"
FT   TOPO_DOM        1..13
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        14..34
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        35..52
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        53..73
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        74..148
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        170..191
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        192..212
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        213..715
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          104..154
FT                   /note="DHHC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00067"
FT   REGION          289..715
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        327..345
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        354..405
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        416..482
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        570..594
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        631..646
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        662..687
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        134
FT                   /note="S-palmitoyl cysteine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
FT   MOD_RES         91
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         294
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         303
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         348
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         350
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         406
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         409
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         411
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         429
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
FT   MOD_RES         432
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         436
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         617
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         621
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         659
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         694
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C0B5"
FT   MOD_RES         697
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDZ4"
SQ   SEQUENCE   715 AA;  77430 MW;  C142840D11C0E494 CRC64;
     MPAESGKRFK PSKYVPVSAA AIFLVGATTL FFAFTCPGLS LDVSPAVPIY NAIMFLFVLA
     NFSMATFMDP GIFPRAEEDE DKEDDFRAPL YKTVEIKGIQ VRMKWCATCR FYRPPRCSHC
     SVCDNCVEEF DHHCPWVNNC IGRRNYRYFF LFLLSLTAHI MGVFGFGLLY VLCHIEELSG
     VRTAVTMAVM CVAGLFFIPV AGLTGFHVVL VARGRTTNEQ VTGKFRGGVN PFTNGCCNNV
     SRVLCSSPAP RYLGRPKKEK TIVIRPPFLR PEVSDGQITV KIMDNGIQGE LRRTKSKGSL
     EITESQSADA EPPPPPKPDL SRYTGLRTHL SLATNEDSSL LGKDSPPTPT MYKYRPGYSS
     SSTSAAMPHS SSAKLSRGDS LKEPTSIADS SRHPSYRSEP SLEPESFRSP TFGKSFHFDP
     LSSGSRSSSL KSAQGTGFEL GQLQSIRSEG TTSTSYKSLA NQTRNGSLSY DSLLTPSDSP
     DFESVQAGPE PDPPLGYTSP FLSARLAQQR EAERHPRLLP TGPPHREPSP VRYDNLSRHI
     VASLQEREKL LRQSPPLAGR EEEPGLGDSG IQSTPGSGHA PRTSSSSDDS KRSPLSKTPL
     GRPAVPRFGK PDGLRGRGLG SPEPGTTAPY LGRSMSYSSQ KAPSGVSETE EVALQPLLTP
     KDEVQLKTTY SKSNGQPKSI GSASPGPGQP PLSSPTRGGV KKVSGVGGTT YEISV
//
